SEC Filings

SEC Filings

Filing date Description Form View

Quarterly report which provides a continuing view of a company's financial position

 10-Q View HTML
0001558370-22-017869.pdf
0001558370-22-017869.rtf
0001558370-22-017869.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Statement of changes in beneficial ownership of securities

 4 View HTML
0001235802-22-000136.pdf
0001235802-22-000136.rtf
0001235802-22-000136.xls

Report of unscheduled material events or corporate event

 8-K View HTML
0001558370-22-018843.pdf
0001558370-22-018843.rtf
0001558370-22-018843.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Report of unscheduled material events or corporate event

 8-K View HTML
0001558370-22-019017.pdf
0001558370-22-019017.rtf
0001558370-22-019017.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Registration statement for face-amount certificate companies

 S-1 View HTML
0001104659-23-003466.pdf
0001104659-23-003466.rtf
0001104659-23-003466.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

UPLOAD

 UPLOAD View HTML
0000000000-23-000677.pdf
0000000000-23-000677.rtf

Amended Registration statement for face-amount certificate companies

 S-1/A View HTML
0001104659-23-007102.pdf
0001104659-23-007102.rtf
0001104659-23-007102.xls

Report of unscheduled material events or corporate event

 8-K View HTML
0001104659-23-007172.pdf
0001104659-23-007172.rtf
0001104659-23-007172.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

CORRESP

 CORRESP View HTML
0001104659-23-009433.pdf
0001104659-23-009433.rtf
0001104659-23-009433.xls

CORRESP

 CORRESP View HTML
0001104659-23-009432.pdf
0001104659-23-009432.rtf
0001104659-23-009432.xls
Displaying 1301 - 1310 of 1362 results

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE